Purple Biotech Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 22, 2023 at 08:23 am EDT
Purple Biotech Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 5.14 million compared to USD 3.54 million a year ago. Basic loss per share was USD 0.25 compared to USD 0.20 a year ago. Diluted loss per share was USD 0.25 compared to USD 0.20 a year ago.
For the six months, net loss was USD 10.02 million compared to USD 10.83 million a year ago. Basic loss per share was USD 0.49 compared to USD 0.61 a year ago. Diluted loss per share was USD 0.49 compared to USD 0.61 a year ago.